FDC Ltd. — Investor Relations & Filings
FDC Ltd. specializes in the manufacture and marketing of active ingredients and finished dosage forms. The company maintains a diverse portfolio across therapeutic segments, including anti-infectives, gastrointestinals, ophthalmics, and vitamins. It is widely recognized for its leadership in the oral rehydration salts (ORS) market with its flagship brand, Electral. Other notable products include Zifi, a broad-spectrum antibiotic, and Enerzal, a balanced energy drink. The organization operates multiple manufacturing facilities certified by global regulatory bodies and serves a broad range of markets. The company focuses on research and development to enhance its formulation capabilities and expand its footprint through strategic exports and partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Disclosure under SEBI Takeover Regulations | 2026-05-07 | English | |
| Updates | 2026-04-24 | English | |
| Copy of Newspaper Publication | 2026-04-24 | English | |
| Shareholders meeting | 2026-04-22 | English | |
| General Updates | 2026-04-21 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42492038 | Disclosure under SEBI Takeover Regulations | 2026-05-07 | English | ||
| 36126957 | Updates | 2026-04-24 | English | ||
| 36126965 | Copy of Newspaper Publication | 2026-04-24 | English | ||
| 42178664 | Shareholders meeting | 2026-04-22 | English | ||
| 42190539 | General Updates | 2026-04-21 | English | ||
| 42208175 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-10 | English | ||
| 42165679 | Trading Window | 2026-03-26 | English | ||
| 42215546 | Updates | 2026-03-20 | English | ||
| 42173994 | Change in Director(s) | 2026-03-18 | English | ||
| 42162408 | Disclosure under SEBI Takeover Regulations | 2026-02-19 | English | ||
| 42162551 | Disclosure under SEBI Takeover Regulations | 2026-02-19 | English | ||
| 42189419 | General Updates | 2026-02-17 | English | ||
| 42226692 | General Updates | 2026-02-10 | English | ||
| 42169314 | Press Release | 2026-02-05 | English | ||
| 42178913 | Record Date | 2026-02-05 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
|
Ascendis Pharma A/S
Biopharmaceutical firm using its prodrug technology to trea…
|
ASND | DK | Manufacturing |
|
Ascentage Pharma Group International
Integrated biopharma developing novel small molecule therap…
|
6855 | HK | Manufacturing |
|
ASCENTAGE PHARMA GROUP INTERNATIONAL
A clinical-stage biopharma developing novel therapies for c…
|
AAPG | US | Manufacturing |
|
Ascletis Pharma Inc.
R&D driven biotech developing best-in-class therapeutics, p…
|
1672 | KY | Manufacturing |
FDC Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60812/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60812 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60812 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60812 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60812}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for FDC Ltd. (id: 60812)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.